DexCom logo

DexCom Income Statement

Revenue, expenses, and profitability over time

DexCom generated $4.8B in trailing twelve-month revenue, up 0.2% year-over-year. Net income was $930.4M with a 19.31% net margin. Gross margin stands at 61.5% and operating margin at 21.45%. Diluted EPS is $2.33, which grew 0.7% year-over-year. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$25.1B
P/E Ratio27.00
ROE35.62%

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$59.6M$48.9M$61.3M$68.5M$73.4M$70.0M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$151.7M$105.4M$179.8M$283.8M$267.3M$199.5M

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$1.1B$1.0B$1.2B$1.2B$1.3B$1.2B